• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腓肠肌线粒体 DNA 损伤与外周动脉疾病患者的行走能力。

Mitochondrial DNA damage in calf skeletal muscle and walking performance in people with peripheral artery disease.

机构信息

University of Florida, Institute on Aging, Department of Aging and Geriatric Research, Gainesville, FL, USA; Northwestern University Feinberg School of Medicine, Department of Preventive Medicine, Chicago, IL, USA.

Northwestern University Feinberg School of Medicine, Department of Preventive Medicine, Chicago, IL, USA; Northwestern University Feinberg School of Medicine, Department of Medicine, Chicago, IL, USA.

出版信息

Free Radic Biol Med. 2020 Nov 20;160:680-689. doi: 10.1016/j.freeradbiomed.2020.09.004. Epub 2020 Sep 8.

DOI:10.1016/j.freeradbiomed.2020.09.004
PMID:32911084
Abstract

BACKGROUND

Peripheral artery disease (PAD) is associated with mitochondrial dysfunction in calf skeletal muscle and a greater abundance of mitochondrial DNA (mtDNA) heteroplasmy. However, it is unknown whether calf skeletal muscle mtDNA of PAD participants harbors a greater abundance of mitochondrial DNA 4977-bp common deletion (mtDNA), strand breaks and oxidative damage (i.e., oxidized purines) compared to non-PAD participants and whether these mtDNA abnormalities are associated with poor walking performance in participants with PAD.

METHODS

Calf muscle biopsies were obtained from 50 PAD participants (ankle-brachial index (ABI) < 0.95) and 25 non-PAD participants (ABI = 0.99-1.40) matched by age, sex, and race. The abundance of mtDNA copy number, mtDNA deletion, strand breaks, and oxidized purines in selected mtDNA regions coding for electron transport chain (ETC) constituents and the non-coding D-Loop region was determined in calf muscle. All participants completed measurement of 6-min walk and usual and fast-paced 4-m walking velocity test.

RESULTS

Participants with PAD (mean age = 65.4 years, SD = 6.9; 14 (28%) women, 38 (76%) black) and without PAD (mean age = 65.2 years, SD = 6.7; 7 (28%) women, 16 (64%) black) did not differ in the abundance of calf muscle mtDNA deletion, mtDNA strand breaks, and oxidized purines. Though, a greater abundance of mtDNA strand breaks within ND4/5 genes was significantly associated with poorer 6-min walk distance, lower usual-paced 4-m walking velocity, and lower fast-paced 4-m walking velocity in non-PAD participants. Significant associations were also found in the density of strand break damage (i.e., damage per mtDNA copy) within ND1/2, ND4/5 and COII/ATPase 6/8 region with 6-min walk distance, usual-paced 4-m walking velocity and fast-paced 4-m walking velocity in non-PAD participants. Significant interactions were found between PAD presence vs. absence and density of strand break damage within ND1/2, ND4/5, COII/ATPase 6/8 regions for the associations with 6-min walk distance, usual-paced 4-m walking velocity, fast-paced 4-m walking velocity. Conversely, of the three walking performance measures only the usual-paced 4-m walking velocity showed a significant, although modest, negative association with the abundance of oxidized purines in the D-Loop (P = 0.031) and ND4/5 (P = 0.033) regions in the calf skeletal muscle of people with PAD.

CONCLUSION

Overall, these data suggest that the abundance of calf muscle mtDNA strand breaks and mtDNA common deletion are not associated with walking performance in people with PAD and may not be directly involved in the pathophysiology of PAD. Conversely, strand breaks in specific mtDNA regions may contribute to poor walking performance in people without PAD. Further study is needed to confirm whether usual-paced 4-m walking velocity is associated significantly with a greater abundance of oxidized purines in the D-loop, a "mutational hotspot" for oxidative damage, and why this association may differ from the association with 6-min walk distance and fast-paced 4-m walking velocity.

摘要

背景

周围动脉疾病(PAD)与小腿骨骼肌中线粒体功能障碍和更大的线粒体 DNA(mtDNA)异质性相关。然而,尚不清楚 PAD 参与者的小腿骨骼肌 mtDNA 是否比非 PAD 参与者具有更大的线粒体 DNA 4977-bp 常见缺失(mtDNA)、链断裂和氧化损伤(即氧化嘌呤),以及这些 mtDNA 异常是否与 PAD 参与者的行走能力较差有关。

方法

从 50 名 PAD 参与者(踝臂指数(ABI)<0.95)和 25 名非 PAD 参与者(ABI=0.99-1.40)中获得小腿肌肉活检,这些参与者按年龄、性别和种族进行匹配。在选定的编码电子传递链(ETC)成分和非编码 D 环区的 mtDNA 区域中,确定了 mtDNA 拷贝数、mtDNA 缺失、链断裂和氧化嘌呤的丰度。所有参与者均完成了 6 分钟步行和常规及快速 4 米步行速度测试。

结果

PAD 参与者(平均年龄 65.4 岁,标准差 6.9;14 名(28%)女性,38 名(76%)黑人)和无 PAD 参与者(平均年龄 65.2 岁,标准差 6.7;7 名(28%)女性,16 名(64%)黑人)在小腿肌肉 mtDNA 缺失、mtDNA 链断裂和氧化嘌呤的丰度上没有差异。然而,ND4/5 基因内更大的 mtDNA 链断裂与非 PAD 参与者的 6 分钟步行距离较短、常规步伐 4 米步行速度较低和快速步伐 4 米步行速度较低显著相关。在非 PAD 参与者中,还发现了 ND1/2、ND4/5 和 COII/ATPase 6/8 区域内的链断裂损伤密度(即每 mtDNA 拷贝的损伤)与 6 分钟步行距离、常规步伐 4 米步行速度和快速步伐 4 米步行速度之间存在显著相关性。在 PAD 存在与否与 ND1/2、ND4/5、COII/ATPase 6/8 区域内的链断裂损伤密度之间的相关性中发现了显著的相互作用,用于与 6 分钟步行距离、常规步伐 4 米步行速度和快速步伐 4 米步行速度相关。相反,在三种步行表现测量中,只有常规步伐 4 米步行速度与 PAD 参与者小腿骨骼肌 D 环(P=0.031)和 ND4/5(P=0.033)区域 mtDNA 氧化嘌呤的丰度呈显著负相关,尽管相关性较弱。

结论

总体而言,这些数据表明,小腿骨骼肌 mtDNA 链断裂和 mtDNA 常见缺失的丰度与 PAD 患者的步行表现无关,并且可能与 PAD 的病理生理学无关。相反,特定 mtDNA 区域的链断裂可能会导致非 PAD 患者的步行表现不佳。需要进一步研究以确认常规步伐 4 米步行速度是否与 D 环中更大的氧化嘌呤丰度(氧化损伤的“突变热点”)显著相关,以及为什么这种关联与 6 分钟步行距离和快速步伐 4 米步行速度的关联不同。

相似文献

1
Mitochondrial DNA damage in calf skeletal muscle and walking performance in people with peripheral artery disease.腓肠肌线粒体 DNA 损伤与外周动脉疾病患者的行走能力。
Free Radic Biol Med. 2020 Nov 20;160:680-689. doi: 10.1016/j.freeradbiomed.2020.09.004. Epub 2020 Sep 8.
2
Associations of Poly (ADP-Ribose) Polymerase1 abundance in calf skeletal muscle with walking performance in peripheral artery disease.小牛骨骼肌中聚(ADP-核糖)聚合酶1丰度与外周动脉疾病步行能力的关联。
Exp Gerontol. 2020 Oct 15;140:111048. doi: 10.1016/j.exger.2020.111048. Epub 2020 Aug 2.
3
Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance.外周动脉疾病、小腿骨骼肌线粒体 DNA 拷贝数与功能表现。
Vasc Med. 2018 Aug;23(4):340-348. doi: 10.1177/1358863X18765667. Epub 2018 May 8.
4
Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy.外周血管疾病与小腿骨骼肌线粒体 DNA 异质性的相关性。
J Am Heart Assoc. 2020 Apr 7;9(7):e015197. doi: 10.1161/JAHA.119.015197. Epub 2020 Mar 21.
5
Mitochondrial Complex Abundance, Mitophagy Proteins, and Physical Performance in People With and Without Peripheral Artery Disease.线粒体复合物丰度、线粒体自噬蛋白与外周动脉疾病患者和非外周动脉疾病患者的身体表现。
J Am Heart Assoc. 2023 Mar 21;12(6):e027088. doi: 10.1161/JAHA.122.027088. Epub 2023 Mar 9.
6
The ankle brachial index independently predicts walking velocity and walking endurance in peripheral arterial disease.踝臂指数可独立预测外周动脉疾病患者的步行速度和步行耐力。
J Am Geriatr Soc. 1998 Nov;46(11):1355-62. doi: 10.1111/j.1532-5415.1998.tb06001.x.
7
Vitamin D status and functional performance in peripheral artery disease.维生素 D 状态与外周动脉疾病的功能表现。
Vasc Med. 2012 Oct;17(5):294-302. doi: 10.1177/1358863X12448457. Epub 2012 Jul 19.
8
The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease.踝臂指数、比目鱼肌线粒体呼吸测定法与周围动脉疾病患者和非患者的步行能力。
Vasc Med. 2024 Dec;29(6):640-652. doi: 10.1177/1358863X241268893. Epub 2024 Sep 6.
9
Walking performance is positively correlated to calf muscle fiber size in peripheral artery disease subjects, but fibers show aberrant mitophagy: an observational study.在周围动脉疾病患者中,步行能力与小腿肌纤维大小呈正相关,但肌纤维显示出异常的线粒体自噬:一项观察性研究。
J Transl Med. 2016 Sep 29;14(1):284. doi: 10.1186/s12967-016-1030-6.
10
Greater sedentary hours and slower walking speed outside the home predict faster declines in functioning and adverse calf muscle changes in peripheral arterial disease.在家外久坐时间较长和行走速度较慢,预示着外周动脉疾病患者的功能下降和小腿肌肉不良变化更快。
J Am Coll Cardiol. 2011 Jun 7;57(23):2356-64. doi: 10.1016/j.jacc.2010.12.038.

引用本文的文献

1
The Dual Role of Exogenous Hydrogen Sulfide (HS) in Intestinal Barrier Mitochondrial Function: Insights into Cytoprotection and Cytotoxicity Under Non-Stressed Conditions.外源性硫化氢(HS)在肠道屏障线粒体功能中的双重作用:对非应激条件下细胞保护和细胞毒性的见解
Antioxidants (Basel). 2025 Mar 25;14(4):384. doi: 10.3390/antiox14040384.
2
The 4977 Bp Deletion of Mitochondrial DNA as a Potential Trait Marker for Major Depressive Disorder.线粒体DNA 4977碱基对缺失作为重度抑郁症的潜在性状标志物
Neuropsychiatr Dis Treat. 2025 Apr 13;21:867-873. doi: 10.2147/NDT.S509050. eCollection 2025.
3
Unveiling the Genetic Footprint: Exploring Somatic Mutations in Peripheral Arterial Disease Progression.

本文引用的文献

1
Na controls hypoxic signalling by the mitochondrial respiratory chain.钠通过线粒体呼吸链控制低氧信号。
Nature. 2020 Oct;586(7828):287-291. doi: 10.1038/s41586-020-2551-y. Epub 2020 Jul 29.
2
Cell-Free Circulating Mitochondrial DNA: A Potential Blood-Based Marker for Atrial Fibrillation.无细胞循环游离线粒体 DNA:一种潜在的基于血液的房颤生物标志物。
Cells. 2020 May 8;9(5):1159. doi: 10.3390/cells9051159.
3
Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy.外周血管疾病与小腿骨骼肌线粒体 DNA 异质性的相关性。
揭示基因印记:探索外周动脉疾病进展中的体细胞突变
Biomedicines. 2023 Aug 17;11(8):2288. doi: 10.3390/biomedicines11082288.
4
2023 Padua Days of Muscle and Mobility Medicine: post-meeting Book of Abstracts.2023年帕多瓦肌肉与运动医学日:会后摘要集
Eur J Transl Myol. 2023 Apr 27;33(2):11427. doi: 10.4081/ejtm.2023.11427.
5
Mitochondrial Complex Abundance, Mitophagy Proteins, and Physical Performance in People With and Without Peripheral Artery Disease.线粒体复合物丰度、线粒体自噬蛋白与外周动脉疾病患者和非外周动脉疾病患者的身体表现。
J Am Heart Assoc. 2023 Mar 21;12(6):e027088. doi: 10.1161/JAHA.122.027088. Epub 2023 Mar 9.
6
Abstracts of the 2023 Padua Days of Muscle and Mobility Medicine (2023Pdm3) to be held March 29 - April 1 at the Galileian Academy of Padua and at the Petrarca Hotel, Thermae of Euganean Hills, Padua, Italy.将于3月29日至4月1日在意大利帕多瓦的伽利略帕多瓦学院以及佩特拉卡酒店(尤加尼安山温泉浴场)举行的2023年帕多瓦肌肉与运动医学日(2023Pdm3)摘要。
Eur J Transl Myol. 2023 Feb 10;33(1). doi: 10.4081/ejtm.2023.11247.
7
The 2022 On-site Padua Days on Muscle and Mobility Medicine hosts the University of Florida Institute of Myology and the Wellstone Center, March 30 - April 3, 2022 at the University of Padua and Thermae of Euganean Hills, Padua, Italy: The collection of abstracts.2022年肌肉与运动医学帕多瓦现场日活动由佛罗里达大学肌病学研究所和韦尔斯通中心主办,于2022年3月30日至4月3日在意大利帕多瓦大学和帕多瓦尤加尼山温泉浴场举行:摘要征集。
Eur J Transl Myol. 2022 Mar 10;32(1):10440. doi: 10.4081/ejtm.2022.10440.
8
Altered Expression of Mitoferrin and Frataxin, Larger Labile Iron Pool and Greater Mitochondrial DNA Damage in the Skeletal Muscle of Older Adults.老年骨骼肌中铁转运蛋白和酵母铁蛋白表达改变、不稳定铁池增大及线粒体DNA损伤加剧
Cells. 2020 Dec 2;9(12):2579. doi: 10.3390/cells9122579.
J Am Heart Assoc. 2020 Apr 7;9(7):e015197. doi: 10.1161/JAHA.119.015197. Epub 2020 Mar 21.
4
Mitochondrial genetic variation is enriched in G-quadruplex regions that stall DNA synthesis in vitro.线粒体遗传变异富集在体外导致 DNA 合成停滞的 G-四链体区域。
Hum Mol Genet. 2020 May 28;29(8):1292-1309. doi: 10.1093/hmg/ddaa043.
5
Mechanisms of mitochondrial DNA escape and its relationship with different metabolic diseases.线粒体 DNA 逃逸的机制及其与不同代谢性疾病的关系。
Biochim Biophys Acta Mol Basis Dis. 2020 Jun 1;1866(6):165761. doi: 10.1016/j.bbadis.2020.165761. Epub 2020 Mar 10.
6
Mitochondrial Structure and Function in the Metabolic Myopathy Accompanying Patients with Critical Limb Ischemia.伴有临界肢体缺血患者的代谢性肌病中的线粒体结构和功能。
Cells. 2020 Feb 28;9(3):570. doi: 10.3390/cells9030570.
7
Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical Trial.可可粉改善外周动脉疾病老年人的步行能力:COCOA-PAD 先导随机临床试验。
Circ Res. 2020 Feb 28;126(5):589-599. doi: 10.1161/CIRCRESAHA.119.315600. Epub 2020 Feb 14.
8
The role of control region mitochondrial DNA mutations in cardiovascular disease: stroke and myocardial infarction.控制区线粒体 DNA 突变在心血管疾病中的作用:中风和心肌梗死。
Sci Rep. 2020 Feb 17;10(1):2766. doi: 10.1038/s41598-020-59631-x.
9
Extensive skeletal muscle cell mitochondriopathy distinguishes critical limb ischemia patients from claudicants.广泛的骨骼肌细胞线粒体病将严重肢体缺血患者与跛行患者区分开来。
JCI Insight. 2018 Nov 2;3(21):123235. doi: 10.1172/jci.insight.123235.
10
Prognostic value of mitochondrial DNA deletion and mitochondrial DNA copy number in patients with stable coronary artery disease.线粒体 DNA 缺失和线粒体 DNA 拷贝数对稳定性冠心病患者的预后价值。
Atherosclerosis. 2018 Sep;276:91-97. doi: 10.1016/j.atherosclerosis.2018.07.015. Epub 2018 Jul 25.